Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot
But some experts say that demand could begin to recede in only a matter of weeks
Oklahoma Supreme Court Overturns $465 Million J&J Opioid Ruling
It is not clear how the decision will affect similar cases nationwide, since most public nuisance laws are state-specific
Pfizer Asks FDA to Approve Booster Shots for All U.S. Adults
With its application, the company included early results of a study that involved 10,000 people
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
Randomized clinical trial shows oral nadolol noninferior to oral propranolol for treatment of infantile hemangiomas
ACR: Certain Serious Infections Down for Psoriatic Arthritis Patients
Hospital discharges for psoriatic arthritis patients with sepsis, skin and soft tissue infections, and UTIs down from 2012 to 2017 in the U.S.
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
Statin Use Not Linked to COVID-19 Mortality in Hospitalized Patients
Statin use associated with increased relative risk for severe disease among hospitalized patients with COVID-19
Biden Administration Presses Schools to Provide COVID-19 Shots to Children
White House also teaming up with AAP to have local physicians provide schools with science-based info about the vaccines
Pfizer Set to Ask FDA to Approve Booster for Those 18 and Older
Approval would fulfill the Biden administration's plan to provide boosters for all adults and could increase booster rates at a critical point in the pandemic
Adults With IBD Show Antibody Response to mRNA COVID-19 Vaccine
After mRNA COVID-19 vaccination, 99 percent of patients with IBD had detectable antibodies regardless of immunocompromising therapies
